{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:41:48Z","timestamp":1791513708264,"version":"4.3.4"},"reference-count":47,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100004681","name":"Higher Education Commission","doi-asserted-by":"publisher","award":["5-9\/PAS\/967"],"award-info":[{"award-number":["5-9\/PAS\/967"]}],"id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sindh HEC of Pakistan","award":["NO.DD\/SHEC\/1-14\/2014"],"award-info":[{"award-number":["NO.DD\/SHEC\/1-14\/2014"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Hyperuricemia is associated with several disease conditions, such as atherosclerosis,\narthritis, kidney stones, and many others. Xanthine oxidase (XO) is an enzyme that catalyzes\nthe conversion of xanthine to uric acid. Hence, XO is a major therapeutic drug target in the\ntreatment of hyperuricemia and associated disorders.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>The current study aimed to identify XO inhibitors based on quinazoline derivatives, with\nthe potential to be used against gout and other hyperuricemia-associated diseases.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>In the current study, eighteen quinazoline derivatives 2-19 were synthesized and assessed\nfor their in vitro xanthine Oxidase (XO) inhibitory activity. Furthermore, the most active compounds,\n5 and 17, were subjected to kinetics studies, followed by computational docking. Human BJ\nfibroblast cells were used to measure the cytotoxicity of active compounds.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Compounds 4-6, 8, 10, 13, 15-17, and 19 were found active against XO, with an IC50 values\nbetween 33.688 to 362.173\u03bcM. The obtained results showed that compounds 5 and 17 possess a significant\nxanthine oxidase inhibitory activity. The kinetics and molecular docking studies suggested\nthat compounds 5 (IC50 = 39.904 \u00b1 0.21 \u03bcM) and 17 (IC50 = 33.688 \u00b1 0.30 \u03bcM) bind in the allosteric\nsite of XO and exhibit a non-competitive type of inhibition. The molecular docking studies also predicted\nthat the NH group of the pyrimidine ring binds with Ser344 residues of XO. Furthermore, all\nactive compounds were non-cytotoxic on the human BJ fibroblasts cell line.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This study identifies a series of quinazoline compounds as xanthine oxidase inhibitors,\nwith the potential to be further investigated.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406418666220620124034","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T06:44:23Z","timestamp":1655793863000},"page":"384-392","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In vitro and In silico Xanthine Oxidase Inhibitory Activities of 3-Aryl-2-\nthioxo-2,3-dihydroquinazolin-4(1H)-one Derivatives"],"prefix":"10.2174","volume":"19","author":[{"given":"Afshan","family":"Gul","sequence":"first","affiliation":[{"name":"H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi,\nKarachi, 75270, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Muhammad","family":"Saad","sequence":"additional","affiliation":[{"name":"H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi,\nKarachi, 75270, Pakistan"},{"name":"Department of Chemistry, University of Karachi, Karachi, 75270, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humaira","family":"Zafar","sequence":"additional","affiliation":[{"name":"Dr. Panjwani\nCenter for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences,\nUniversity of Karachi, Karachi, 75270, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Atia-tul-Wahab","sequence":"additional","affiliation":[{"name":"Dr. Panjwani\nCenter for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences,\nUniversity of Karachi, Karachi, 75270, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid Mohammed","family":"Khan","sequence":"additional","affiliation":[{"name":"H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi,\nKarachi, 75270, Pakistan"},{"name":"Department of Clinical Pharmacy, Institute for Research and Medical\nConsultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 31441, Dammam, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Iqbal","family":"Choudhary","sequence":"additional","affiliation":[{"name":"H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi,\nKarachi, 75270, Pakistan"},{"name":"Dr. Panjwani\nCenter for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences,\nUniversity of Karachi, Karachi, 75270, Pakistan"},{"name":"Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, 22254, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.2174\/0929867323666160725091915","volume":"23","author":"Battelli M.G.","year":"2016","unstructured":"Battelli M.G.; Polito L.; Bortolotti M.; Bolognesi A.; Xanthine oxidoreductase in drug metabolism: Beyond a role as a detoxifying enzyme. Curr Med Chem 2016,23(35),4027-4036","journal-title":"Curr Med Chem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"L830","DOI":"10.1152\/ajplung.00007.2008","volume":"294","author":"Boueiz A.","year":"2008","unstructured":"Boueiz A.; Damarla M.; Hassoun P.M.J.A.J.P-L.C.; Physiology M.; Xanthine oxidoreductase in respiratory and cardiovascular disorders. Am J Physiol Lung Cell Mol Physiol 2008,294(5),L830-L840","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.redox.2015.08.020","volume":"6","author":"Granger D.N.","year":"2015","unstructured":"Granger D.N.; Kvietys P.R.; Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol 2015,6,524-551","journal-title":"Redox Biol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","volume":"213","author":"Maiuolo J.","year":"2016","unstructured":"Maiuolo J.; Oppedisano F.; Gratteri S.; Muscoli C.; Mollace V.; Regulation of uric acid metabolism and excretion. Int J Cardiol 2016,213,8-14","journal-title":"Int J Cardiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.12659\/MSM.899852","volume":"22","author":"Chen C.","year":"2016","unstructured":"Chen C.; L\u00fc J.M.; Yao Q.; Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: An overview. Med Sci Monit 2016,22,2501-2512","journal-title":"Med Sci Monit"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fmed.2018.00160","volume":"5","author":"Benn C.L.","year":"2018","unstructured":"Benn C.L.; Dua P.; Gurrell R.; Loudon P.; Pike A.; Storer R.I.; Vangjeli C.; Physiology of hyperuricemia and urate-lowering treatments. Front Med (Lausanne) 2018,5,160","journal-title":"Front Med (Lausanne)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2741\/3950","volume":"17","author":"Jin M.","year":"2012","unstructured":"Jin M.; Yang F.; Yang I.; Yin Y.; Luo J.J.; Wang H.; Yang X.F.; Uric acid, hyperuricemia and vascular diseases. Front Biosci 2012,17(2),656-669","journal-title":"Front Biosci"},{"key":"ref=8","first-page":"950","volume":"23","author":"Yang D.","year":"2011","unstructured":"Yang D.; Yuan J.J.Z.W.Z.C.J.M.; The treatment of hyperuricemia and microecological treatment progress. Zhongguo Weishengtaxixue Zazhi. Zhongguo Weishengtaixue Zazhi 2011,23(10),950-955","journal-title":"Zhongguo Weishengtaixue Zazhi"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3810\/pgm.2012.11.2616","volume":"124","author":"Doghramji P.P.","year":"2012","unstructured":"Doghramji P.P.; Wortmann R.L.; Hyperuricemia and gout: New concepts in diagnosis and management. Postgrad Med 2012,124(6),98-109","journal-title":"Postgrad Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s11926-013-0400-9","volume":"16","author":"Martillo M.A.","year":"2014","unstructured":"Martillo M.A.; Nazzal L.; Crittenden D.B.; The crystallization of monosodium urate. Curr Rheumatol Rep 2014,16(2),400","journal-title":"Curr Rheumatol Rep"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1124\/pr.58.1.6","volume":"58","author":"Pacher P.","year":"2006","unstructured":"Pacher P.; Nivorozhkin A.; Szab\u00f3 C.; Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol. Pharmacol Rev 2006,58(1),87-114","journal-title":"Pharmacol Rev"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","volume":"382","author":"Badve S.V.","year":"2020","unstructured":"Badve S.V.; Pascoe E.M.; Tiku A.; Boudville N.; Brown F.G.; Cass A.; Clarke P.; Dalbeth N.; Day R.O.; de Zoysa J.R.J.N.E.J.M.; Douglas B.; Faull R.; Harris D.C.; Hawley C.M.; Jones G.R.D.; Kanellis J.; Palmer S.C.; Perkovic V.; Rangan G.K.; Reidlinger D.; Robison L.; Walker R.J.; Walters G.; Johnson D.W.; Effects of allopurinol on the progression of chronic kidney disease. N Engl J Med 2020,382(26),2504-2513","journal-title":"N Engl J Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3899\/jrheum.080814","volume":"36","author":"Becker M.A.","year":"2009","unstructured":"Becker M.A.; Schumacher H.R.; MacDonald P.A.; Lloyd E.; Lademacher C.; Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout. J Rheumatol 2009,36(6),1273-1282","journal-title":"J Rheumatol"},{"key":"ref=14","first-page":"41","author":"Hashem H.E.","year":"2020","unstructured":"Hashem H.E.;  In: Quinazolinone and Quinazoline Derivatives 2020,41","journal-title":"In: Quinazolinone and Quinazoline Derivatives"},{"key":"ref=15","first-page":"2947","volume":"3","author":"Arora P.","year":"2012","unstructured":"Arora P.; Arora V.; Lamba H.; Wadhwa D.J.I.J.P.S.; Research, importance of heterocyclic chemistry: A review. Int J Pharm Sci Res 2012,3(9),2947","journal-title":"Int J Pharm Sci Res"},{"key":"ref=16","first-page":"1","volume":"11","author":"Jafari E.","year":"2016","unstructured":"Jafari E.; Khajouei M.R.; Hassanzadeh F.; Hakimelahi G.H.; Khodarahmi G.A.; Quinazolinone and quinazoline derivatives: Recent structures with potent antimicrobial and cytotoxic activities. Res Pharm Sci 2016,11(1),1-14","journal-title":"Res Pharm Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejmech.2015.04.028","volume":"96","author":"Mendoza-Mart\u00ednez C.","year":"2015","unstructured":"Mendoza-Mart\u00ednez C.; Correa-Basurto J.; Nieto-Meneses R.; M\u00e1rquez-Navarro A.; Aguilar-Su\u00e1rez R.; Montero-Cortes M.D.; Nogueda-Torres B.; Su\u00e1rez-Contreras E.; Galindo-Sevilla N.; Rojas-Rojas \u00c1.; Rodriguez-Lezama A.; Hern\u00e1ndez-Luis F.; Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents. Eur J Med Chem 2015,96,296-307","journal-title":"Eur J Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1016\/j.bmc.2007.03.037","volume":"15","author":"Xu G-F.","year":"2007","unstructured":"Xu G-F.; Song B-A.; Bhadury P.S.; Yang S.; Zhang P-Q.; Jin L-H.; Xue W.; Hu D-Y.; Lu P.; Synthesis and antifungal activity of novel s-substituted 6-fluoro-4-alkyl(aryl)thioquinazoline derivatives. Bioorg Med Chem 2007,15(11),3768-3774","journal-title":"Bioorg Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ejmech.2007.06.010","volume":"43","author":"Chandrika P.M.","year":"2008","unstructured":"Chandrika P.M.; Yakaiah T.; Rao A.R.R.; Narsaiah B.; Reddy N.C.; Sridhar V.; Rao J.V.; Synthesis of novel 4,6-disubstituted quinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines. Eur J Med Chem 2008,43(4),846-852","journal-title":"Eur J Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/molecules22071094","volume":"22","author":"Abuelizz H.A.","year":"2017","unstructured":"Abuelizz H.A.; Dib R.E.; Marzouk M.; Anouar E-H.; A Maklad, Y.; N Attia, H.; Al-Salahi, R. Molecular docking and anticonvulsant activity of newly synthesized quinazoline derivatives. Molecules 2017,22(7),1094","journal-title":"Molecules"},{"key":"ref=21","first-page":"171","volume":"3","author":"Patel H.U.","year":"2013","unstructured":"Patel H.U.; Patel R.S.; Patel C.N.J.J.A.P.S.; Synthesis and antihypertensive activity of some quinazoline derivatives. J Appl Pharm Sci 2013,3(3),171","journal-title":"J Appl Pharm Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.pharep.2019.04.003","volume":"71","author":"Al-Salahi R.","year":"2019","unstructured":"Al-Salahi R.; Taie H.A.A.; Bakheit A.H.; Marzouk M.; Almehizia A.A.; Herqash R.; Abuelizz H.A.J.P.R.; Antioxidant activities and molecular docking of 2-thioxobenzo[g]quinazoline derivatives. Pharmacol Rep 2019,71(4),695-700","journal-title":"Pharmacol Rep"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s00044-014-1293-5","volume":"24","author":"Gurram V.","year":"2015","unstructured":"Gurram V.; Garlapati R.; Thulluri C.; Madala N.; Kasani K.S.; Machiraju P.K.; Doddapalla R.; Addepally U.; Gundla R.; Patro B.J.M.C.R.; Pottabathini N.; Design, synthesis, and biological evaluation of quinazoline derivatives as \u03b1-glucosidase inhibitors. Med Chem Res 2015,24(5),2227-2237","journal-title":"Med Chem Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2174\/1573406410666150807111336","volume":"12","author":"Zafar H.","year":"2016","unstructured":"Zafar H.; Saad S.M.; Perveen S.; Arshia; Malik, R.; Khan, A.; Khan, K.M.; Choudhary, M.I. 2-Arylquinazolin-4(3H)-ones: Inhibitory activities against xanthine oxidase. Med Chem 2016,12(1),54-62","journal-title":"Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0021-9258(17)30998-5","volume":"167","author":"Kalckar H.M.","year":"1947","unstructured":"Kalckar H.M.; Differential spectrophotometry of purine compounds by means of specific enzymes; determination of adenine compounds. J Biol Chem 1947,167(2),445-459","journal-title":"J Biol Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1016\/j.bmc.2017.02.044","volume":"25","author":"Zafar H.","year":"2017","unstructured":"Zafar H.; Hayat M.; Saied S.; Khan M.; Salar U.; Malik R.; Choudhary M.I.; Khan K.M.J.B.; Xanthine oxidase inhibitory activity of nicotino\/isonicotinohydrazides: A systematic approach from in vitro, in silico to in vivo studies. Bioorg Med Chem 2017,25(8),2351-2371","journal-title":"Bioorg Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"e0235030","DOI":"10.1371\/journal.pone.0235030","volume":"15","author":"Choudhary M.I.","year":"2020","unstructured":"Choudhary M.I.; Shaikh M.; Tul-Wahab A.; Ur-Rahman A.; In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation. PLoS One 2020,15(7),e0235030","journal-title":"PLoS One"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bioorg.2018.04.021","volume":"79","author":"Fatima I.","year":"2018","unstructured":"Fatima I.; Zafar H.; Khan K.M.; Saad S.M.; Javaid S.; Perveen S.; Choudhary M.I.; Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles. Bioorg Chem 2018,79,201-211","journal-title":"Bioorg Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2174\/1573406413666171129224919","volume":"14","author":"Zafar H.","year":"2018","unstructured":"Zafar H.; Iqbal S.; Javaid S.; Khan K.M.; Choudhary M.I.; Xanthine oxidase inhibitory and molecular docking studies on pyrimidones. Med Chem 2018,14(5),524-535","journal-title":"Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2174\/1568026616666161117112604","volume":"17","author":"Zhang X.","year":"2017","unstructured":"Zhang X.; Perez-Sanchez H.; Lightstone F.C. F.J.C.t.i.m.c.; A comprehensive docking and MM\/GBSA rescoring study of ligand recognition upon binding antithrombin. Curr Top Med Chem 2017,17(14),1631-1639","journal-title":"Curr Top Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"282","DOI":"10.2174\/1570180812666150907204007","volume":"13","author":"Moolchand Thadhani V.","year":"2016","unstructured":"Moolchand Thadhani V.; Khan A.; Javaid S.; Shafqat A.; Choudhary M.I.J.L.D.D.; Discovery, study of binding epitopes by STD-NMR spectroscopy and molecular docking of urease inhibitors from lichens. Lett Drug Des Discov 2016,13(4),282-294","journal-title":"Lett Drug Des Discov"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/bcpt.12790","volume":"121","author":"Mannerstr\u00f6m M.","year":"2017","unstructured":"Mannerstr\u00f6m M.; Toimela T.; Sarkanen J.R.; Heinonen T.; Pharmacology, c.; toxicology, Human BJ fibroblasts is an alternative to mouse BALB\/c 3T3 cells in in vitro neutral red uptake assay. Basic Clin Pharmacol Toxicol 2017,121(Suppl. 3),109-115","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=33","first-page":"6612177","volume":"2021","author":"El-Azab A.S.","year":"2021","unstructured":"El-Azab A.S.; Khalil N.Y.; Abdel-Aziz A.A-M.; Remarkable conversion of 2-Thioxo-2, 3-dihydroquinazolin-4 (1H)-ones into the corresponding quinazoline-2, 4 (1H, 3H)-diones: Spectroscopic analysis and X-ray crystallography. J Chem 2021,2021,6612177","journal-title":"J Chem"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"130889","DOI":"10.1016\/j.molstruc.2021.130889","volume":"1244","author":"Ansari S.","year":"2021","unstructured":"Ansari S.; Mohammadi-Khanaposhtani M.; Asgari M.S.; Esfahani E.N.; Biglar M.; Larijani B.; Rastegar H.; Hamedifar H.; Mahdavi M.; Tas R.; Design, synthesis, in vitro and in silico biological assays of new quinazolinone-2-thio-metronidazole derivatives. J Mol Struct 2021,1244,130889","journal-title":"J Mol Struct"},{"key":"ref=35","first-page":"2486","volume":"26","author":"Yan G.","year":"2020","unstructured":"Yan G.; Zekarias B.L.; Li X.; Jaffett V.A.; Guzei I.A.; Golden J.E.; Divergent 2-Chloroquinazolin-4 (3H)-one rearrangement: Twisted-cyclic guanidine formation or ring-fused N-Acylguanidines via a domino process. Chemistry (Weinheim an der Bergstrasse, Germany, 2020,26(11),2486","journal-title":"Chemistry (Weinheim an der Bergstrasse, Germany,"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1021\/jm00308a057","volume":"11","author":"Gupta C.M.","year":"1968","unstructured":"Gupta C.M.; Bhaduri A.P.; Khanna N.M.; Drugs acting on the central nervous system. Syntheses of substituted quinazolones and quinazolines and triazepino- and triazocinoquinazolones. J Med Chem 1968,11(2),392-395","journal-title":"J Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11094-021-02371-7","volume":"55","author":"Narendhar B.","year":"2021","unstructured":"Narendhar B.; Chitra K.; Alagarsamy V.; Synthesis of new 1-substituted-3-(3-(2-chlorophenyl)-4-Oxo-3, 4-dihydrobenzo-pyrimidin-2-ylamino) isothioureas as anti-HIV and antibacterial agents. Pharm Chem J 2021,55(1),54-59","journal-title":"Pharm Chem J"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00044-018-2276-8","volume":"28","author":"Wang H-X.","year":"2019","unstructured":"Wang H-X.; Liu H-Y.; Li W.; Zhang S.; Wu Z.; Li X.; Li C-W.; Liu Y-M.; Chen B-Q.; Design, synthesis, antiproliferative and antibacterial evaluation of quinazolinone derivatives. Med Chem Res 2019,28(2),203-214","journal-title":"Med Chem Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s11030-015-9623-1","volume":"19","author":"Zhang H-J.","year":"2015","unstructured":"Zhang H-J.; Wang S-B.; Quan Z-S.; Synthesis and antidepressant activities of 4-(substituted-phenyl)tetrazolo[1,5-a]quinazolin-5(4H)-ones and their derivatives. Mol Divers 2015,19(4),817-828","journal-title":"Mol Divers"},{"key":"ref=40","unstructured":"[https:\/\/www.aldlab.com\/en\/productind.html"},{"key":"ref=41","author":"Gil A.M.","year":"2017","unstructured":"Gil A.M.; Ayuso-Gontan C.B.G.; Garc\u00eda Fern\u00e1ndez A.M.; P\u00e9rez Fern\u00e1ndez D.I.; S-substituted quinazolines and their therapeutic applications for the treatment of diseases mediated by PDE7. Quinazolinas S-sustituidas y sus aplicaciones terap\u00e9uticas para el tratamiento de enfermedades mediadas por PDE7. U.S. Patent 9796687B2, October 24, 2017"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"103422","DOI":"10.1016\/j.bioorg.2019.103422","volume":"94","author":"Mahdy H.A.","year":"2020","unstructured":"Mahdy H.A.; Ibrahim M.K.; Metwaly A.M.; Belal A.; Mehany A.B.M.; El-Gamal K.M.A.; El-Sharkawy A.; Elhendawy M.A.; Radwan M.M.; Elsohly M.A.; Eissa I.H.; Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers. Bioorg Chem 2020,94,103422","journal-title":"Bioorg Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1134\/S1070428018040152","volume":"54","author":"Markosyan A.","year":"2018","unstructured":"Markosyan A.; Hayrapetyan K.; Gabrielyan S.; Shirinyan V.; Mamyan S.; Avakimyan J.; Stepanyan G.; Some transformations of 2-(chloromethyl)-5, 5-dimethyl-5, 6-dihydrobenzo [h] quinazolin-4 (3 H)-one. Russ J Org Chem 2018,54(4),606-613","journal-title":"Russ J Org Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.3987\/R-1987-09-2371","volume":"26","author":"Garin J.","year":"1987","unstructured":"Garin J.; Guillen C.; Melendez E.; Merchan F.L.; Orduna J.; N-Halosuccinimide\/sulfuric acid: An efficient reagent for the synthesis of fused benzothiazoles. Heterocycles (Sendai) 1987,26(9),2371-2379","journal-title":"Heterocycles (Sendai)"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3762\/bjoc.15.155","volume":"15","author":"N\u00e9meth A.G.","year":"2019","unstructured":"N\u00e9meth A.G.; Keser\u0171 G.M.; \u00c1br\u00e1nyi-Balogh, P. A novel three-component reaction between isocyanides, alcohols or thiols and elemental sulfur: A mild, catalyst-free approach towards O-thiocarbamates and dithiocarbamates. Beilstein J Org Chem 2019,15(1),1523-1533","journal-title":"Beilstein J Org Chem"},{"key":"ref=46","volume":"30","author":"Banerjee R.","year":"1999","unstructured":"Banerjee R.; Lakhan R.; Shukla B.; Simple preparation of 1-Methyl-3-aryl-2-thio-2, 4 (1H, 3H)-quinazolinediones as potential antimicrobial agents. ChemInform no-no.1999,30(8)","journal-title":"ChemInform"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/ajoc.201700443","volume":"6","author":"Zhou Z.W.","year":"2017","unstructured":"Zhou Z.W.; Jia F.C.; Xu C.; Jiang S.F.; Wu Y.D.; Wu A.X.; Temperature-controlled base\u2010promoted cyclization for the synthesis of 2-amino-4H-benzo [d][1, 3] thiazin-4-ones and 2-thioxo-4 (3H)-quinazolinones. Asian J Org Chem 2017,6(12),1773-1777","journal-title":"Asian J Org Chem"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406418666220620124034","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/206197\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406418666220620124034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T11:26:50Z","timestamp":1692185210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/206197\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406418666220620124034","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}